The Canadian Free Press reported that the Supreme Court of Canada has ruled to remove limitations on what counts as a legally acceptable form of medical marijuana. Users may consume marijuana in the form of cookies, brownies, oils and teas. The decision has angered Health Minister Rona Ambrose. As quoted in the publication: Until now, federal […]
Read More
Growblox Sciences Inc. (OTCMKTS:GBLX) announced that it’s established a majority owned subsidiary called Growblox Sciences Puerto Rico LLC (GBS PR). It is domiciled in Puerto Rico.
Read More
Growblox Sciences Inc. (OTCMKTS:GBLX) announced that it’s established a majority owned subsidiary called Growblox Sciences Puerto Rico LLC (GBS PR). It is domiciled in Puerto Rico.
Read More
Two NASDAQ-traded cannabis companies have announced earnings this past week. The companies, Insys Therapeutics and GW Pharmaceuticals, are focused on improving daily life for millions of people around the world by developing medicines derived from cannabis.
Read More
Wildflower Marijuana Inc. (CSE:SUN) announced that it’s entered a letter of intent (LOI) to market, wholesale and distribute what it describes as “most advanced cannabidiol vaporizer product on the market for the State of Washington.”
Read More
T-Bird Pharma Inc. (TSXV:TPI) announced that it will be receiving funding from the National Research Council of Canada-IRAP. The money will go towards research and development work regarding the company’s strains of medical cannabis.
Read More
Canadian Bioceutical Corp. (TSXV:BCC) announced that its subsidiary’s application under Health Canada’s Marijuana for Medical Purposes Regulations (MMPR) is moving forward.
Read More
T-Bird Pharma Inc. (TSXV:TPI) announced that Health Canada has confirmed the renewal of the production license for Thunderbird Biomedical Inc., its subsidiary.
Read More
Wildflower Marijuana Inc. (CSE:SUN) announced that it’s signed a letter of intent (LOI) to license “the most advanced technology for the delivery of oil based derivatives in the disposable vaporizer industry.”
Read More
International Goldfields Ltd. (ASX:IGS) announced that it’s entered into a binding heads of agreement (HOA) to gain an 85-percent interest in Winter Garden Biosciences, an Uruguay-based biosciences and pharmaceuticals company.
Read More